Página 2 - Melhores Timoma médicos - TOP-57 médicos

O Professor Ondzhel é especialista em oncocirurgia com foco em cancros colorretais e retais, realizando procedimentos complexos no Hospital Universitário Medipol Mega.

• Formado na Cleveland Clinic – líder em cirurgia colorretal
• Proctologista certificado pela Comissão Europeia com mais de 25 anos de experiência
• Investigação publicada sobre adenocarcinoma retal e ressecção de cancro multivisceral
• Chefe do Departamento de Cirurgia da Universidade Medipol de Istambul
• Membro fundador da Eurasian Colorectal Technologies Association

O Dr. Yildiz especializa-se em timoma e tumores neuroendócrinos, com vasta investigação publicada em revistas médicas internacionais.

• Publicar mais de 17 estudos sobre condições oncológicas raras
• Experiência no diagnóstico e tratamento de casos complexos de timoma
• Trabalhar no Medipol Mega University Hospital – um centro de oncologia de referência

O Prof. Univ. Dr. Wolfgang Köstler é um especialista líder em terapias direcionadas para o cancro, com mais de duas décadas de experiência em oncologia médica.

• Especializar-se em cancro da mama e neoplasias ginecológicas
• Subchefe da Divisão Clínica de Oncologia da Universidade Médica de Viena
• Concentrar-se na terapia sistémica individualizada contra o cancro e na imunoterapia
• Investigação publicada sobre o desenvolvimento de biomarcadores e biologia tumoral

O Prof. Walter Klepetko foi pioneiro nos primeiros transplantes de pulmão na Áustria e estabeleceu um dos principais programas de cirurgia torácica da Europa na Universidade de Medicina de Viena.

• Mais de 40 anos de especialização em oncologia torácica complexa e transplante pulmonar
• Ex-Diretor de Cirurgia Torácica da Universidade de Medicina de Viena
• Desenvolver técnicas minimamente invasivas avançadas para tumores torácicos
• Renomado por lidar com casos de alto risco e ressecções complexas

O Professor Keil é especialista em técnicas avançadas de imagem para o diagnóstico preciso de timoma no Centro Médico em Solingen.

• Graduar-se com honras pela Julius-Maximilians-Universität Würzburg
• Especialista em diagnósticos por RM, TC e ultrassonografia
• Médico-Chefe de Radiologia Diagnóstica e Intervencionista desde 2022
• Formar-se com radiologistas renomados na Alemanha
• Oferecer uma gama completa de serviços de radiologia intervencionista

O Dr. Felix Dobritoiu utiliza técnicas minimamente invasivas de ponta, como cirurgia robótica (da Vinci Xi) e VATS uniportal, para o tratamento de timoma no Ponderas Academic Hospital.

• Especializado em cirurgia torácica com experiência em ressecções mediastinais complexas
• Utilizar pequenas incisões para uma recuperação mais rápida e redução da dor pós-operatória
• Realizar procedimentos sem drenagem pleural pós-operatória, quando possível
• Treinado em técnicas avançadas, incluindo o procedimento de Nuss

O Prof. Associado Nail Paksoy traz sua experiência do Instituto de Oncologia da Universidade de Istambul e do Hospital Medipol Bahçelievler, com foco em timoma e outras malignidades torácicas.

• Certificado pela ESMO em Oncologia Médica desde 2022
• Redigir pesquisas sobre cancros torácicos raros publicadas em revistas internacionais
• Participar em 8 ensaios clínicos internacionais para novas terapias contra o cancro
• Especializar-se em imunoterapia e abordagens de terapia-alvo

O Dr. Alemdar é especialista no tratamento de timoma, com vasta experiência em oncologia médica nos principais hospitais turcos.

• Formado pela Universidade de Akdeniz – uma instituição médica de prestígio na Turquia
• Mais de 15 anos de experiência em oncologia e medicina interna
• Trabalha no Medical Park Antalya Hospital Complex – equipado com instalações avançadas para o tratamento do cancro
• Membro da Associação Turca de Oncologia Médica

Mais de 30 anos de experiência em imunologia – A Dra. Jaunalksne é especialista em viroterapia, uma área de vanguarda no tratamento do timoma.

• Chefiar o Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Licenciar-se no Instituto de Medicina de Riga com estágio em Medicina Interna
• Focar-se em abordagens imunológicas inovadoras

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Amr Mahmoud Al Demery is a consultant thoracic surgical oncologist with 12 years of experience. He holds an M.B.B.Ch from Kasr El-Aini, Cairo University (2007). He earned a Master’s in Surgical Oncology in 2014 and a Doctorate in Surgical Oncology in 2019 from the National Cancer Institute, Cairo University. He is a Member of the Royal College of Surgeons of England (MRCS, 2014). He speaks English and Arabic.

His practice includes the assessment, diagnosis, and surgical treatment of thoracic cancers. He performs bronchoscopy, thoracoscopy, and mediastinoscopy. He carries out lung resections, including wedge resection, lobectomy, bilobectomy, and pneumonectomy. He also performs esophageal resection with reconstruction and pleural decortication. His work includes thymectomy and mediastinal lymph node dissection. He performs chest wall and diaphragmatic tumor resection with reconstruction.

He served as Resident, Assistant Lecturer, and Lecturer of Surgical Oncology at the National Cancer Institute, Cairo University. He is a consultant in thoracic surgical oncology at Dar El-Salam, Tanta, Damanhour, and Shefaa Al Orman Cancer Centers. He is a member of the Egyptian Society of Surgical Oncology. He is a cofounder and member of the Egyptian Society of Respiratory Neoplasms.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

O Dr. Erkan Karatas traz uma vasta formação internacional para o seu trabalho no Hospital Universitário Atlas, com especialização em otorrinolaringologia e cirurgia de cabeça e pescoço.

• Formação em instituições de prestígio em todo o mundo, incluindo a Universidade de Munique e a Universidade Estadual de Ohio
• Especialização em implantes cocleares e abordagens endoscópicas com formação pela empresa Medel
• Membro de múltiplas sociedades profissionais, incluindo a Academia Americana de Otorrinolaringologia
• Estudos avançados concluídos em otologia e neurotologia na Alemanha e nos EUA

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).